Latest Regulatory Approval News

Southern Cross Gold Consolidated Ltd. has achieved a pivotal regulatory milestone enabling underground exploration at its Sunday Creek project, backed by strong drilling results and a robust cash position of $130.4 million.

Neuren Pharmaceuticals’ partner Acadia projects DAYBUE sales to reach around US$700 million by 2028, driven by US market expansion and international approvals. The launch of a new formulation and ongoing clinical trials in Japan underpin this optimistic outlook.

Brightstar Resources has secured key regulatory approvals for the Lady Shenton open pit mine in Menzies, positioning the company to accelerate production within its Goldfields Hub. The deposit is now 'mine ready' and will feed into Brightstar’s planned Laverton processing plant.

The Foreign Investment Review Board has extended its deadline to assess Caterpillar’s proposed acquisition of RPMGlobal, pushing the decision to 23 January 2026. This procedural extension keeps the deal on track but leaves some questions open for shareholders.

McLaren Minerals’ Pre-Feasibility Study confirms a robust, low-risk titanium mining project in Western Australia, projecting nearly A$900 million EBITDA over 16 years. The study highlights strong market demand and validated processing methods, setting the stage for the next development phase.

Horizon Oil has approved a strategic $1.5 million investment to install a booster compressor at its Nam Phong gas field in Thailand, aiming to increase production by at least 40% by mid-2026.

Tetratherix has successfully completed the second safety review of its TetraDerm clinical trial's second cohort, showing no adverse events and confirming a strong safety profile. The trial now progresses to its final phase, targeting a growing reconstructive surgery market.

Miramar Resources is set to launch a multi-commodity drilling campaign in early 2026, focusing on gold targets near Kalgoorlie and high-grade copper-lead-silver mineralisation in the Gascoyne region.

Lunnon Metals reports standout drilling results at Lady Herial, revealing thick, high-grade gold mineralisation beyond current open pit plans and setting the stage for expanded mining activity.

Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.